Company / Assets per Share
Traws Pharma, Inc. Assets per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$2.91
FY2024
5-year range
$0.18 / $4.78
FY2020-FY2024
Trend
+168.3%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share returned to growth in FY2024 after 2 years of decline, reaching $2.91.
Based on SEC 10-K filings.
2.91 in FY2024 with a 5-year CAGR of -7.0%.
Improved from $1.88 to $2.91 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -15.3%
- 5-Year CAGR
- -7.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, assets per share increased 168.3% year-over-year.
- Peak assets per share was recorded in FY2018.
- Lowest assets per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -42.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $2.91 | +168.3% |
| FY2023 | $1.08 | -42.5% |
| FY2022 | $1.88 | -60.6% |
| FY2021 | $4.78 | +2557.5% |
| FY2020 | $0.18 | -95.7% |
| FY2019 | $4.17 | -83.3% |
| FY2018 | $24.96 | +3288.7% |
| FY2017 | $0.74 | -91.9% |
| FY2016 | $9.12 | +744.6% |
| FY2015 | $1.08 | -51.0% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026